Bioptik Technology (Taiwan) Insiders
| 4161 Stock | TWD 26.55 0.10 0.38% |
Bioptik Technology employs about 17 people. The company is managed by 4 executives with a total tenure of roughly 61 years, averaging almost 15.0 years of service per executive, having 4.25 employees per reported executive. Recap of Bioptik Technology's management performance can provide insight into the venture performance.
| Yao Tu CEO Co-CEO-Zhuke |
| Jinchang Yang Chairman Chairman of the Board, General Manager |
Bioptik |
Bioptik Technology Management Team Effectiveness
Bioptik Technology's management efficiency ratios could be used to measure how well Bioptik Technology manages its routine affairs as well as how well it operates its assets and liabilities.Bioptik Technology holds a total of 48.27 Million outstanding shares. Bioptik Technology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Bioptik Technology in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Bioptik Technology, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Bioptik Technology Workforce Comparison
Bioptik Technology is number one stock in number of employees category among its peers. The total workforce of Medical Devices industry is presently estimated at about 1,684. Bioptik Technology claims roughly 17.0 in number of employees contributing just under 2% to all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.05 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Bioptik Technology Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioptik Technology Price Series Summation is a cross summation of Bioptik Technology price series and its benchmark/peer.
Bioptik Technology Notable Stakeholders
A Bioptik Technology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bioptik Technology often face trade-offs trying to please all of them. Bioptik Technology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bioptik Technology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Yao Tu | Co-CEO-Zhuke | Profile | |
| Jinchang Yang | Chairman of the Board, General Manager | Profile | |
| Kun Wu | Ex Officer | Profile | |
| Yi Wu | Ex Officer | Profile |
About Bioptik Technology Management Performance
The success or failure of an entity such as Bioptik Technology often depends on how effective the management is. Bioptik Technology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioptik management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioptik management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Bioptik Technology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioptik Technology. Check Bioptik Technology's Beneish M Score to see the likelihood of Bioptik Technology's management manipulating its earnings.
Bioptik Technology Workforce Analysis
Traditionally, organizations such as Bioptik Technology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bioptik Technology within its industry.Bioptik Technology Manpower Efficiency
Return on Bioptik Technology Manpower
| Revenue Per Employee | 43.4M | |
| Revenue Per Executive | 184.5M | |
| Net Income Per Employee | 1.3M | |
| Net Income Per Executive | 5.6M |
Additional Tools for Bioptik Stock Analysis
When running Bioptik Technology's price analysis, check to measure Bioptik Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioptik Technology is operating at the current time. Most of Bioptik Technology's value examination focuses on studying past and present price action to predict the probability of Bioptik Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioptik Technology's price. Additionally, you may evaluate how the addition of Bioptik Technology to your portfolios can decrease your overall portfolio volatility.